Skip to main content

2020 News

2020 News | 2019 Archives | 2018 Archives | 2017 Archive | 2016 Archive | 2015 Archive

Tuesday, June 02, 2020

UM School of Medicine’s Institute of Human Virology Awarded Grants to Strengthen COVID-19 Response in Sub-Saharan Africa

The Center for International Health, Education and Biosecurity (Ciheb) at the University of Maryland School of Medicine’s Institute of Human Virology was awarded $4 million from the U.S. Centers for Disease Control and Prevention (CDC) to support coronavirus disease 2019 (COVID-19) response activities in Botswana, Nigeria, Malawi, and Mozambique.

Monday, May 11, 2020

BBC Global News Interviews Dr. Robert Gallo on Oral Polio Vaccine for SARS-CoV-2 and More

Dr. Robert Gallo appeared on BBC World News with Matthew Amroliwala for a one-on-one, lengthy interview during their Coronavirus Explained segment.

Saturday, May 09, 2020

Dr. Robert Gallo Discuss COVID-19 Research on Aljazeera News

Aljazeera discusses the status of therapy, testing and vaccine research on SARS-CoV-2/COVID-19 with Dr. Robert Gallo.

Thursday, May 07, 2020

The Disappointing Truth About Antibody Testing: There’s still a lot we don’t know about COVID-19

Dr. Robert Gallo discusses the status of COVID-19 antibody test with Vox's The Verge

Wednesday, May 06, 2020

The Coronavirus Appears to have Mutated. What Does that Mean for Contagiousness?

While small mutations in the virus's genetic code are evident, it's unclear what these changes mean for people, if anything at all.

Saturday, May 02, 2020

IHV's Dr. Robert Gallo on FOX's Full Court Press with Greta Van Susteren

Overtime: Dr. Robert Gallo talks coronavirus treatments and antibody testing.

Saturday, May 02, 2020

Dr. Robert Gallo on iHeart Radio to Discuss COVID-19

Ryan Gorman hosts an iHeartRadio nationwide special featuring experts on COVID-19-related issues, including the co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine, the senior vice president for U.S. Programs & Advocacy at Save the Children, and the managing editor of the Military Times. Topics range from a discussion about why some people infected by the coronavirus are asymptomatic, while others face severe reactions and even death, to assistance for impoverished children, and a breakdown of the impact the virus is having on the U.S. military and veterans.

Friday, May 01, 2020

Could an Oral Polio Vaccine Stop the Coronavirus Pandemic?

A YouTube video by the American Chemical Society and produced by PBS.

Friday, May 01, 2020

NYT Op-Ed Features Gallo-Chumakov Oral Polio Vaccine for COVID-19 Idea

What if We Already Have a Coronavirus Vaccine? Researchers are testing whether decades-old vaccines for polio and tuberculosis could protect against infection.

Wednesday, April 29, 2020

Dr. Robert Gallo Appears on C-SPAN’s Washington Journal

Please check out Dr. Robert Gallo’s C-SPAN Washington Journal appearance today to discuss COVID-19 treatments, vaccines, the need for the Global Virus Network, and more.

Monday, April 27, 2020

Expert Breaks Down Coronavirus Research: Is it Worse than HIV? Is it Mutating?

IHV Co-Founder and Director, Robert Gallo, MD is interviewed on LBC, a radio station in the United Kingdom. Darren Adam had Professor Gallo on the line to discuss his research in the past and the work he's carrying out during the coronavirus crisis. "We have learned to live with HIV" Darren began, listing out how it has changed from a death sentence to a disease that humans can live a long life with. He wondered if this could be possibly the path we're taking with Covid-19.

Wednesday, April 22, 2020

Dr. Robert Gallo Featured on National Geographic’s “Jane Goodall: The Hope” on 50th Anniversary of Earth Day

For the 50th anniversary of Earth Day on April 22, 2020, the National Geographic channel will broadcast back-to-back premieres of Photo Ark: Rarest Creatures and Jane Goodall: The Hope.

Wednesday, April 22, 2020

Dr. Robert Gallo on India Today Discussing the Oral Polio Vaccine for COVID-19

IndiaToday on Twitter - “Can oral polio vaccine help in fighting #Covid19? @DrRobertCGallo responds. #NewsToday with @sardesairajdeep

Tuesday, April 21, 2020

USA Today Opinion: An Old Vaccine Could be a New Godsend for Coronavirus

Ultimate control over COVID-19 will be possible only after a large part of the world population becomes immune. This can happen either after a large fraction of the world population gets infected or by prophylactic vaccination. Efforts are underway to accelerate the development of safe and effective vaccines. However, vaccines can be used for mass immunization only if they prove to be safe and effective by thorough clinical evaluation. Given the time this requires, vaccines specific to COVID-19 are likely to remain unavailable for mass immunization during the current pandemic.

Friday, April 17, 2020

Dr. Robert Gallo Discusses Repurposing the Oral Polio Vaccine on CNN

Dr. Robert Gallo discusses repurposing the oral polio vaccine, drug therapies and more on COVID-19 on CNN’s The Lead with Jake Tapper, April 17, 2020.

Monday, April 13, 2020

Can an Oral Polio Vaccine Stop COVID-19?

Please see this just released Associated Press article, “Could old vaccines for other germs protect against COVID-19?” with Dr. Robert Gallo (Institute of Human Virology at the University of Maryland School of Medicine) and Dr. Konstantin Chumakov (U.S. Food and Drug Administration), both of the Global Virus Network (GVN).

Saturday, April 11, 2020

Institute of Human Virology Honors Legacy of Maeve Kennedy McKean With Global Public Health Fellowship

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today the Maeve Kennedy McKean Global Public Health Fellowship, named in honor of the public health activist, whose inspiring life ended tragically alongside her oldest son last week. The first fellow will arrive on July 1 and will work on the Institute’s efforts in ending the HIV epidemic in Africa within its Center for International Health, Education, and Biosecurity (CIHEB) and Division of Clinical Care and Research.

Thursday, April 09, 2020

IHV and Italian Scientists Identify Unique Mutations in SARS-CoV-2 Found in Europe and North America

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine and scientists from Trieste, Italy announced today the characterization of a novel mutation in the RNA polymerase of certain viral strains of SARS-Cov-2 carried by patients located in Europe and North America. In addition, different patterns of mutations were identified in viral strains corresponding to different geographical areas.

Wednesday, April 08, 2020

Institute of Human Virology Co-founder on Coronavirus Recovery, Antibody Testing, Drug Testing, Bloomberg TV

Dr. Robert Gallo, the Institute of Human Virology at the University of Maryland School of Medicine, Co-founder and director discusses the coronavirus. He speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Asia." (Source: Bloomberg)

Tuesday, April 07, 2020

A Deep Look Into The Coronavirus with Dr. Robert Gallo on WYPR (Baltimore’s local NPR station)

(WNPR) Dr. Robert Gallo has been getting to know viruses-- their targets and their weaknesses--for decades, even before he co-discovered the virus that causes AIDS in the 1980s. At the University of Maryland’s Institute for Human Virology, which he heads, Gallo is looking at the coronavirus; he joins us to share his thoughts. Gallo is also co-founder and international scientific advisor at the Global Virus Network.

Wednesday, April 01, 2020

Dr. Robert Gallo Featured on MSNBC’s 11th Hour with Brian Williams

Robert Gallo, MD, Co-Founder and Director of the Institute of Human Virology, discusses SARS-CoV-2/COVID-19, specifically, how he thinks the fight against the Coronavirus is going thus far.

Friday, March 27, 2020

Covid-19 Is Probably Seasonal, But That’s No Reason to Relax (The Washington Post)

Mohammad Sajadi and Anthony Amoroso are associate professors of medicine at the Institute of Human Virology at the University of Maryland School of Medicine and members of the Global Virus Network. As physicians and researchers, we have spoken to doctors across the country over the past few weeks and kept hearing variations on this description of the novel coronavirus’s spread: It’s like a chemical bomb went off. One day everything seemed normal, and the next everyone became sick: patients, nurses, family members.

Tuesday, March 24, 2020

Maryland Receives Kits for 1,000 Coronavirus Tests from Chinese Company (The Baltimore Sun)

(Source: The Baltimore Sun) A Chinese company has delivered kits for 1,000 coronavirus tests to Maryland through the Institute of Human Virology at the University of Maryland School of Medicine, according to Dr. Robert Gallo, the eminent virologist who leads the institute in downtown Baltimore.

Thursday, March 19, 2020

What COVID-19 Symptoms Look Like, Day By Day

(Source: Business Insider) According to the World Health Organization-China Joint Mission on COVID-19, as of February 20, 80% of laboratory-confirmed cases were mild to moderate, 14% were severe, and 6% were critical. Just to be clear, a mild case of COVID-19 is not like a mild cold. The symptoms will still be pretty severe. Anything less than needing oxygen puts you in this category. Severe cases do need supplemental oxygen, and critical ones are defined by respiratory or multi-organ failure.

Thursday, March 12, 2020

Researchers Predict Potential Spread and Seasonality for COVID-19 Based on Climate Where Virus Appears to Thrive

Researchers at the Institute of Human Virology at the University of Maryland School of Medicine (UMSOM) and the Global Virus Network (GVN) predict that COVID-19 will follow a seasonal pattern similar to other respiratory viruses like seasonal flu. They base this on weather modeling data in countries where the virus has taken hold and spread within the community.

Monday, February 24, 2020

Institute of Human Virology and OncoImmune Launch Clinical Trial to Lessen Effects of HIV Later in Infection

On February 1, the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and OncoImmune, Inc. launched a new Phase II clinical trial called CALIBER, which will test whether OncoImmune’s lead product, CD24Fc, can reduce late effects of HIV infection, such as inflammatory abnormalities including cardiovascular disease. This is intended for use in HIV patients who have been receiving the traditional antiretroviral therapies that control, but do not cure, HIV infection.

Tuesday, February 18, 2020

IHV Clinician Selected as UMSOM 2020 Fellow of the Academy of Education Excellence

Devang M. Patel, MD, Assistant Professor of Medicine, Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), was selected as a UMSOM 2020 Fellow of the Academy of Educational Excellence, established by Carolyn J. Pass, MD ’66 and Richard J. Susel, MD ’66. This honor, which was made possible through the generosity of Dr. Pass and Dr. Susel, is designed to recognize faculty members and other educators who demonstrate excellence in bedside, classroom and/or innovative medical education.

Thursday, February 06, 2020

IHV Joins Global Virus Network (GVN) Discussions with International Top Experts to Combat Growing Novel Coronavirus Epidemic

The GVN, with support from the IHV, Is Bridging Gaps in the Global Emergency Response and Serving as a “Go-To” Resource for Members Needing Assistance in Obtaining and Disseminating Cutting-Edge Scientific Research.